44th Annual ASPO Conference
In response to the rapidly changing circumstances associated with the Novel Coronavirus (COVID-19), the ASPO Board of Directors has made the decision to convert the Annual Meeting in Tucson to a virtual meeting. The Board of Directors and Planning Committee carefully weighed the risks to attendees and their communities and determined that the canceling the live meeting was the best course of action. The health and safety of attendees is our top priority.
Please know, this was a difficult decision – the ASPO team and University of Arizona host committee were looking forward to welcoming all of you in Tucson in a few weeks. Our leadership has met daily for the past week to determine the best and safest course of action. ASPO is a non-profit organization and as such we have had to balance all decisions to ensure that we protect the health of meeting attendees and their communities and workplaces, as well as remain stable as an organization and fulfill our vision to accelerate progress towards cancer prevention and control.
More information here: https://aspo.org/annual-meeting/.
- Jennifer Bea, PhD, University of Arizona Cancer Center | Symposium 1: Community Science Initiatives – “Restoring balance in Indian Country”
- Sherry Chow, PhD, University of Arizona Cancer Center | Concurrent Breakfast Session 1: Lifestyle Behaviors, Energy Balance and Chemoprevention and Survivorship – “The role of Metformin in cancer chemoprevention: Evidence from the NCI chemoprevention consortia”
- Tracy Crane, PhD, RDN, University of Arizona | Concurrent Breakfast Session 1: Lifestyle Behaviors, Energy Balance and Chemoprevention and Survivorship – “Diet and physical activity to improve patient symptoms and quality of life”
- Jessica Martinez, PhD, University of Arizona | Paper Session 1: Risk Factors and Mechanisms of Breast & Colorectal Cancer Incidence and Survival – “Oxylipins Correlate with Quality of Life in Women Taking Aromatase Inhibitors for Breast Cancer”